{
    "nctId": "NCT03859453",
    "briefTitle": "Follow-up in Early and Locally Advanced Breast Cancer Patients",
    "officialTitle": "Follow-up in Early and Locally Advanced Breast Cancer Patients",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 830,
    "primaryOutcomeMeasure": "Health-related quality of life",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically proven Early Breast Cancer (EBC) and Locally Advanced Breast Cancer (LABC) patients who have completed their primary treatment (except endocrine therapy), between 12 months and 36 months after the diagnosis.\n* Disease-free without any evidence of relapse\n* Age \u2265 18 years.\n* Ability to understand and fill out questionnaires.\n* Written informed consent.\n\nExclusion Criteria:\n\n* Metastatic breast cancer (defined as secondary spread to other organs, such as bones, lung, liver, mediastinal lymph nodes) or DCIS.\n* Other cancer diagnosis in the past 5 years except non-melanotic skin cancer or cervical intraepithelial neoplasia.\n* Male breast cancer.\n* Patients on maintenance therapy (other than endocrine therapy).\n* Patients participating in interventional clinical studies with Quality of Life as primary endpoint.\n* Any psychological (including preexisting psychiatric disorders), familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}